GSK
803 hedge funds and large institutions have $11.2B invested in GSK in 2019 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 289 increasing their positions, 287 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
803
Holders Change
-43
Holders Change %
-5.08%
% of All Funds
17.47%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.3%
New
60
Increased
289
Reduced
287
Closed
92
Calls
$98M
Puts
$74.7M
Net Calls
+$23.2M
Net Calls Change
-$87.3M
Top Buyers
| 1 |
Jane Street
New York
|
$72.7M |
| 2 |
Renaissance Technologies
New York
|
$611M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$44.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$731M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$85.3M |
